Anzeige
Mehr »
Login
Sonntag, 03.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 25.06.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
25.06.Greenvolt Group revenues exceeds €100 million in the 1Q242The Greenvolt Group recorded revenues of €101.6 million in the first quarter of 2024, as increase of almost 60% explained by the strong growth in the Utility Scale segment and Distributed Generation...
► Artikel lesen
25.06.CPH Group AG startet neue Ära nach erfolgreicher Abspaltung des Papiergeschäfts127• Die Trennung des Papierbereichs von den Chemie- und Verpackungsaktivitäten ist erfolgreich abgeschlossen • Die neu firmierte CPH Group AG strebt weiteres organisches und anorganisches Wachstum an •...
► Artikel lesen
25.06.Fragbite Group AB: Bulletin from the Extraordinary General Meeting in Fragbite Group AB (publ)98Fragbite Group AB (publ) ("Fragbite Group" or "the Company") has today, 25 June 2024, held an Extraordinary General Meeting (the "EGM"). The EGM resolved to approve the Board of Directors' proposal...
► Artikel lesen
25.06.PEXA GROUP LIMITED: PEXA Group Response to ARNECC Ministerial Forum-
25.06.BHG Group AB: BHG significantly reduces warehouse space after consolidation and successful reduction of inventory and writes down parts of inventory140Consolidations and substantially decreased inventory levels enable BHG Group ("BHG") to reduce warehouse space, which is expected to lead to reduced rent costs of approximately SEK 38 million on an...
► Artikel lesen
25.06.Substrate Artificial - Notice of Extraordinary General Meeting-
25.06.Appili Therapeutics Inc.: Appili Therapeutics Reports Fiscal Year 2024 Financial and Operational Results303LIKMEZ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL launched and commercial sales ongoing Funding commitments from U.S. Air Force Academy intended to advance ATI-1701 toward an IND submission...
► Artikel lesen
25.06.Base Carbon Inc.: Base Carbon Announces Annual General and Special Meeting Results99TORONTO, June 25, 2024 (GLOBE NEWSWIRE) -- Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp. (together, with affiliates...
► Artikel lesen
25.06.Lifeist Wellness Inc. Signs Agreements with Simply Solventless Concentrates Ltd.160TORONTO, June 25, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science...
► Artikel lesen
25.06.Twelve Seas Investment Company II Announces Termination of its Business Combination Agreement with Crystal Lagoons, Expected Filing of Form 25 and Final Redemption Amount127New York, NY, June 25, 2024 (GLOBE NEWSWIRE) -- Twelve Seas Investment Company II (the "Company") today announced that its previously announced Agreement and Plan of Merger in connection with its...
► Artikel lesen
25.06.Annexon Biosciences: Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guillain-Barré Syndrome at the 2024 PNS Annual Meeting154ANX005-Treated Patients Demonstrated Faster and More Complete Recovery from Week 1 through Week 26 on Primary and Multiple Pre-Specified Endpoints Two and a Half Times More ANX005-Treated Patients...
► Artikel lesen
25.06.FLINT Corp.: FLINT Announces Voting Results from Shareholders' Meeting85CALGARY, Alberta, June 25, 2024 (GLOBE NEWSWIRE) -- FLINT Corp. ("FLINT") (TSX: FLNT) is pleased to announce that all matters presented for approval at its annual and special meeting (the "Meeting")...
► Artikel lesen
25.06.Fennec Pharmaceuticals Inc.: Fennec Announces Results of Annual Meeting131RESEARCH TRIANGLE PARK, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the "Company") (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy...
► Artikel lesen
25.06.Worthington Enterprises, Inc.: Worthington Enterprises Reports Fourth Quarter Fiscal 2024 Results423COLUMBUS, Ohio, June 25, 2024 (GLOBE NEWSWIRE) -- Worthington Enterprises, Inc. (NYSE: WOR) reported net sales of $318.8 million and a net loss from continuing operations of $31.5 million, or $(0.64)...
► Artikel lesen
25.06.Progress Software Corporation: Progress Announces Second Quarter 2024 Financial Results126Second Quarter Revenues and Earnings Per Share Ahead of GuidanceRaising Full Year Revenue and Earnings Per Share Outlook BURLINGTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Progress (Nasdaq: PRGS)...
► Artikel lesen
25.06.Methode Electronics, Inc.: Methode Electronics Appoints Jon DeGaynor as President and CEO325 Methode Electronics to Announce Fourth Quarter Fiscal 2024 Results on Thursday, July 11, 2024 Seasoned CEO Brings Deep Experience in Engineered Products and Track Record of Driving Successful Strategic...
► Artikel lesen
25.06.Tecnoglass Inc.: Tecnoglass Board of Directors Announces Review of Strategic Alternatives274- Reiterates Full Year 2024 Outlook - Miami, FL, June 25, 2024 (GLOBE NEWSWIRE) -- Tecnoglass, Inc. (NYSE: TGLS) ("Tecnoglass" or the "Company"), a leading producer of high-end aluminum and vinyl...
► Artikel lesen
25.06.Allakos Inc.: Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile212- AK006 achieved serum concentrations consistent with levels demonstrating inhibitory activity in preclinical experiments -- Skin biopsies from subjects treated with AK006 show high receptor occupancy...
► Artikel lesen
25.06.Intellia Therapeutics, Inc.: Intellia Announces Positive Clinical Proof-of-Concept Data for Redosing a CRISPR-Based Therapy with its Proprietary LNP-Based Delivery Platform97First-ever clinical data demonstrating redosing with an investigational in vivo CRISPR-based therapyFollow-on dosing with a 55 mg dose of NTLA-2001 led to a 90% median reduction in serum TTR at day...
► Artikel lesen
25.06.Automotive Finco Corp. Announces Results of Shareholders' Meeting156Not for distribution to United States newswire services or for dissemination in the United States. This news release does not constitute an offer to sell or a solicitation of an offer to buy any...
► Artikel lesen
Seite:  Weiter >>